Sarepta Therapeutics earnings were -$136.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SRPT earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$4.9M, down 101.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SRPT reported annual earnings of -$713.4M, with -403.3% growth. The next SRPT earnings date is Nov 2, 2026.
Sarepta Therapeutics Earnings Reports & History FAQ
What were Sarepta Therapeutics's earnings last quarter?
On SRPT's earnings call on Aug 5, 2026, Sarepta Therapeutics (NASDAQ: SRPT) reported Q2 2026 earnings per share (EPS) of -$0.05, up 102.49% year over year. Total SRPT earnings for the quarter were -$4.89 million. In the same quarter last year, Sarepta Therapeutics's earnings per share (EPS) was $2.01.
The next SRPT earnings call is Nov 2, 2026. Add SRPT to your watchlist to be reminded of Sarepta Therapeutics's next earnings date.
Is Sarepta Therapeutics profitable or losing money?
As of the last Sarepta Therapeutics earnings report, Sarepta Therapeutics is currently losing money. Sarepta Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$136.73 million, a 135.91% increase year over year.
What was SRPT's earnings growth in the past year?
As of Sarepta Therapeutics's earnings date in Aug 5, 2026, Sarepta Therapeutics's earnings has grown year over year. SRPT earnings in the past year totalled -$136.73 million.
What are Sarepta Therapeutics's earnings expectations?
The current EPS estimate for Sarepta Therapeutics's earnings report in Nov 2, 2026 is $0.30.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.